Trademark: 97682024
Word
MB MAINLINE BIOSCIENCES
Status Date
Thursday, May 2, 2024
Filing Date
Thursday, November 17, 2022
Published for Opposition
Tuesday, June 4, 2024
5 Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
42 Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
The mark consists of a stylized "M" to the left of a stylized "B" to the left of the stylized wording "MAINLINE BIOSCIENCE".
Color is not claimed as a feature of the mark.
"BIOSCIENCES"
Nov 21, 2022
New Application Entered
Dec 9, 2022
New Application Office Supplied Data Entered
Aug 30, 2023
Assigned To Examiner
Sep 1, 2023
Non-Final Action Written
Sep 1, 2023
Non-Final Action E-Mailed
Sep 1, 2023
Notification Of Non-Final Action E-Mailed
Dec 1, 2023
Teas Response To Office Action Received
Apr 22, 2024
Assigned To Lie
Apr 22, 2024
Correspondence Received In Law Office
Apr 22, 2024
Teas/Email Correspondence Entered
Apr 30, 2024
Examiners Amendment -Written
Apr 30, 2024
Examiners Amendment E-Mailed
Apr 30, 2024
Notification Of Examiners Amendment E-Mailed
Apr 30, 2024
Examiner's Amendment Entered
Apr 30, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24
